deferasirox 250 MG Tablet for Oral Suspension
- RxCUI
- 597770
- RxNorm name
- deferasirox 250 MG Tablet for Oral Suspension
- Display name
- deferasirox 250 MG Tablet for Oral Suspension
- Full name
- deferasirox 250 MG Tablet for Oral Suspension
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:53
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Exjade | DEFERASIROX | Novartis Pharmaceuticals Corporation | 3495a70c-870c-4968-940e-8baea152cf85 | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | 597770 |
| Deferasirox | DEFERASIROX | Novadoz Pharmaceuticals LLC | a03c7657-fdca-4acb-ad82-c24680e90eae | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 597770 |
| Deferasirox | DEFERASIROX | Actavis Pharma, Inc. | ad73cb1f-41d6-4cde-9abc-fc2cb7e04c95 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 597770 |
| Deferasirox | DEFERASIROX | Ascend Laboratories, LLC | da3295fc-5210-46a3-a5cc-7b9ec9265eca | 2025-07-11 | Boxed warning, Warnings, Adverse reactions | 597770 |
| Deferasirox | DEFERASIROX | Bionpharma Inc. | dc690f20-533e-490e-b13d-143382e02351 | 2025-03-05 | Boxed warning, Warnings, Adverse reactions | 597770 |
| deferasirox | DEFERASIROX | Glenmark Pharmaceuticals Inc., USA | 59f1d3fb-5bdb-4261-8557-9a4bde8b3c1c | 2024-11-26 | Boxed warning, Warnings, Adverse reactions | 597770 |
| Deferasirox | DEFERASIROX | Teva Pharmaceuticals, Inc. | e9054806-2721-4736-9aef-81ffb8db75d1 | 2024-07-01 | Boxed warning, Warnings, Adverse reactions | 597770 |
| deferasirox | DEFERASIROX | Sun Pharmaceutical Industries, Inc. | 4a2e1bd2-9f3a-40ec-94a2-bc76350d6d4b | 2023-12-26 | Boxed warning, Warnings, Adverse reactions | 597770 |
| Deferasirox | DEFERASIROX | Alembic Pharmaceuticals Inc. | 1f9f1a69-bf71-4e6a-88b0-90f08c4da79f | 2023-03-16 | Boxed warning, Warnings, Adverse reactions | 597770 |
| Deferasirox | DEFERASIROX | Alembic Pharmaceuticals Limited | 8c8b84f3-6887-4485-b5e0-03f254b88a15 | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | 597770 |
| Deferasirox | DEFERASIROX | Dr. Reddy's Laboratories Inc | e365e748-4b61-94f2-fb7a-f81919eaccaa | 2020-12-30 | Boxed warning, Warnings, Adverse reactions | 597770 |
| Deferasirox | DEFERASIROX | MSN LABORATORIES PRIVATE LIMITED | e0726c9c-cee8-4fc1-abd1-68ad0db030dd | 2020-12-22 | Boxed warning, Warnings, Adverse reactions | 597770 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3495a70c-870c-4968-940e-8baea152cf85 | deferasirox 250 MG Tablet for Oral Suspension | SCD | 49 | These highlights do not include all the information needed to use EXJADE safely and effectively. See full prescribing information for EXJADE. EXJADE ® (deferasirox) tablets, for oral suspension Initial U.S. Approval: 2005 | 20260128 |
| 3495a70c-870c-4968-940e-8baea152cf85 | deferasirox 250 MG Tablet for Oral Suspension | PSN | 49 | These highlights do not include all the information needed to use EXJADE safely and effectively. See full prescribing information for EXJADE. EXJADE ® (deferasirox) tablets, for oral suspension Initial U.S. Approval: 2005 | 20260128 |
| ad73cb1f-41d6-4cde-9abc-fc2cb7e04c95 | deferasirox 250 MG Tablet for Oral Suspension | PSN | 29 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20251009 |
| ad73cb1f-41d6-4cde-9abc-fc2cb7e04c95 | deferasirox 250 MG Tablet for Oral Suspension | SCD | 29 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20251009 |
| da3295fc-5210-46a3-a5cc-7b9ec9265eca | deferasirox 250 MG Tablet for Oral Suspension | PSN | 17 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20250711 |
| da3295fc-5210-46a3-a5cc-7b9ec9265eca | deferasirox 250 MG Tablet for Oral Suspension | SCD | 17 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20250711 |
| 1f9f1a69-bf71-4e6a-88b0-90f08c4da79f | deferasirox 250 MG Tablet for Oral Suspension | SCD | 17 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets for oral suspension Initial U.S. Approval: 2005 | 20230316 |
| 1f9f1a69-bf71-4e6a-88b0-90f08c4da79f | deferasirox 250 MG Tablet for Oral Suspension | PSN | 17 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets for oral suspension Initial U.S. Approval: 2005 | 20230316 |
| e0726c9c-cee8-4fc1-abd1-68ad0db030dd | deferasirox 250 MG Tablet for Oral Suspension | SCD | 13 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20201222 |
| e0726c9c-cee8-4fc1-abd1-68ad0db030dd | deferasirox 250 MG Tablet for Oral Suspension | PSN | 13 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20201222 |
| 4a2e1bd2-9f3a-40ec-94a2-bc76350d6d4b | deferasirox 250 MG Tablet for Oral Suspension | PSN | 11 | These highlights do not include all the information needed to use DEFERASIROX TABLETS safely and effectively. See full prescribing information for DEFERASIROX TABLETS. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20231226 |
| 4a2e1bd2-9f3a-40ec-94a2-bc76350d6d4b | deferasirox 250 MG Tablet for Oral Suspension | SCD | 11 | These highlights do not include all the information needed to use DEFERASIROX TABLETS safely and effectively. See full prescribing information for DEFERASIROX TABLETS. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20231226 |
| e9054806-2721-4736-9aef-81ffb8db75d1 | deferasirox 250 MG Tablet for Oral Suspension | SCD | 7 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20240701 |
| e9054806-2721-4736-9aef-81ffb8db75d1 | deferasirox 250 MG Tablet for Oral Suspension | PSN | 7 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20240701 |
| 59f1d3fb-5bdb-4261-8557-9a4bde8b3c1c | deferasirox 250 MG Tablet for Oral Suspension | PSN | 5 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20241126 |
| 59f1d3fb-5bdb-4261-8557-9a4bde8b3c1c | deferasirox 250 MG Tablet for Oral Suspension | SCD | 5 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20241126 |
| dc690f20-533e-490e-b13d-143382e02351 | deferasirox 250 MG Tablet for Oral Suspension | PSN | 4 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets for oral suspension Initial U.S. Approval: 2005 | 20250305 |
| dc690f20-533e-490e-b13d-143382e02351 | deferasirox 250 MG Tablet for Oral Suspension | SCD | 4 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets for oral suspension Initial U.S. Approval: 2005 | 20250305 |
| 8c8b84f3-6887-4485-b5e0-03f254b88a15 | deferasirox 250 MG Tablet for Oral Suspension | PSN | 2 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets for oral suspension Initial U.S. Approval: 2005 | 20230130 |
| 8c8b84f3-6887-4485-b5e0-03f254b88a15 | deferasirox 250 MG Tablet for Oral Suspension | SCD | 2 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets for oral suspension Initial U.S. Approval: 2005 | 20230130 |
| e365e748-4b61-94f2-fb7a-f81919eaccaa | deferasirox 250 MG Tablet for Oral Suspension | PSN | 2 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20201230 |
| e365e748-4b61-94f2-fb7a-f81919eaccaa | deferasirox 250 MG Tablet for Oral Suspension | SCD | 2 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20201230 |
| a03c7657-fdca-4acb-ad82-c24680e90eae | deferasirox 250 MG Tablet for Oral Suspension | SCD | 1 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20251212 |
| a03c7657-fdca-4acb-ad82-c24680e90eae | deferasirox 250 MG Tablet for Oral Suspension | PSN | 1 | These highlights do not include all the information needed to use DEFERASIROX TABLETS FOR ORAL SUSPENSION safely and effectively. See full prescribing information for DEFERASIROX TABLETS FOR ORAL SUSPENSION. DEFERASIROX tablets, for oral suspension Initial U.S. Approval: 2005 | 20251212 |